Despite general acceptance of metabolic radiolabeling as an innocuous treatment, several reports have demonstrated that radioisotopes can induce DNA fragmentation (1) and elevation of p53 (2, 3), a tumor suppressor protein that is a key cell cycle checkpoint regulator that monitors DNA damage. One group associated the radioisotope-induced elevation of p53 with sustained growth arrest or apoptosis, depending on the cell type (3) . Such harmful effects of radiolabels may not be apparent in the absence of deliberate attempts to induce cells to divide in a synchronous manner, which may explain why there is relatively little documentation of this phenomenon. On the other hand, the radiotoxicity of low-energy beta emitters has been long appreciated by radiobiologists (4 -6), although not investigated at the molecular level or within the context of cell cycle progression.
Although the implications of radiation damage induced by radioisotopes during metabolic labeling have not been widely considered, many studies have focused on the molecular and cellular effects of ␥-and UV radiation (7) (8) (9) (10) (11) . For example, UV irradiation of cells has been shown to cause G1 as well as G2 checkpoint arrest involving p53-dependent induction of p21
Cip1/Waf1 or phosphorylation of inhibitory residues of cdc2, respectively (7, 8) . ␥-Irradiation has also been shown to induce p53-dependent cell cycle arrest that can be manifested over multiple cell cycles (11) . In addition, ␥-irradiation has been associated with reduced long-term survival or clonogenicity of cells in culture (11) . In both cases, the primary target of radiation damage is DNA, thus activating the DNA damage molecular sensors at both the G1 (p53) and G2 (cdc2) checkpoints. With respect to low-energy ␤-emitting radioisotopes, the targets as well as mechanism(s) of radiation damage are neither well understood nor well investigated. We report here that [
35 S]methionine at normal doses used in metabolic labeling studies substantially interferes with cell cycle progression and survival.
MATERIALS AND METHODS

Chemicals
Nocodazole, thymidine, L-mimosine, L-methionine, and propidium iodide were obtained from Sigma (St. Louis, Mo.). Annexin V-Oregon Green was obtained from Trevigen, Inc. (Gaithersburg, Md.). All media and buffers were purchased from Fisher (Pittsburgh, Pa.).
35 S-Trans label was purchased from ICN (Irvine, Calif.) and both [ 35 S]methionine in vivo cell label were purchased from Amersham (Arlington Heights, Ill.). ICN and Amersham kindly made available to us the corresponding carrier buffers in which the labels were dissolved for use in our unlabeled controls.
Cells and culture media
Two different lines of rabbit smooth muscle cells (A6 and B1) were kindly provided by Dr. Gene Liau (Novartis Pharmaceuticals). The A6 line is a cell line transfected with the gene for human acidic fibroblast growth factor (FGF-1 ) in plasmid p267-3. The B1 line was transfected with the plasmid alone. Both of these cell lines were cultured in M199 medium supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, Ga.), 2 mM glutamine, antibiotic/antimycotic solution to final concentrations of 100 U/ml penicillin, 100 g/ml streptomycin, 0.25 g/ml amphotericin B, and geneticin at 250 g/ml. The NIH 3T3 murine fibroblasts were obtained from Dr. Patricia Berg (GWUMC) and were cultured in Dulbecco's minimum essential medium (DMEM) supplemented with 10% FBS. The human prostate carcinoma cell line, DU145, was obtained from Dr. Mahnaz Badamchian (GWUMC) and cultured in DMEM:F12 (1:1) medium supplemented with 10% FBS. Other than the experiments described in Fig. 2 , the A6 rabbit smooth muscle line was used for all experiments described in this report.
Mitotic arrest and cell synchronization protocols
Unsynchronized cells were incubated with the radiolabel at 100 Ci/ml for 2 h in prewarmed Met-deficient DMEM supplemented with 10% dialyzed FBS, 2 mM L-Gln, antibiotic/antimycotic, and 1 mg/l cold Met before addition of nocodazole (Sigma) at 0.04 g/ml and overnight incubation to accumulate mitotic cells (ϳ15 h). The control cells were treated with equivalent volumes of the respective carrier buffers instead of the label. The number of mitotic cells (those that were visibly rounded on the culture dish) were counted within several 20ϫ fields on an Olympus CK inverted phase contrast microscope.
Cells were synchronized to the G1/S interface by a thymidine/mimosine double block procedure (12) . This involved an intial 12 h treatment with 2 mM thymidine, followed by a wash and further culture in complete M199 medium (10 -12 h). A second block was induced with mimosine (400 M) for 12-14 h, at which time the cells were arrested in G1 as confirmed by PI staining and scanning laser cytometry (see Fig. 3A ).
Cell cycle analysis of anchored cells
Cell cycle analyses were performed on propidium iodide (PI) -stained anchored cells as described previously (13) . To quantitate cell-associated PI fluorescence, cells were fixed at 2 h intervals after release from the mimosine block with 50% cold methanol/phosphate-buffered saline (PBS) for 0.5 h at 4°C and then stained with PI (0.05 mg/ml in 0.1% sodium citrate, pH 7) for 4 min at 4°C. The PI staining was done either with or without prior RNase treatment (1 mg/ml for 30 min at 37°C) of the fixed cells with the same results. Fluorescence analyses were performed using a Meridian ACAS 570 Interactive Laser Cytometer and the Image Analysis program, with excitation of the fluor at 488 nm. The program automatically collects and processes fluorescence values over a programmable region of the culture dish. Basically, 5-10 areas (720 ϫ 720 ) were analyzed per sample for cell-associated fluorescence. Histograms depicting the fluorescence profile of a minimum of 1956 cells were prepared using the Meridian Instrument's 'Histogram' program, which combines data from the different fields examined. Figure 3 depicts the relative number of cells as a function of integrated fluorescence.
Proliferation assays
In a short-term assay, cells were labeled for 2 h with 35 S-Trans label at 100 Ci/ml, washed, and then left in culture for the indicated number of days before counting viable cells with a hemacytometer. Trypan blue staining immediately after labeling did not reveal any significant decrease in cell viability.
For the colony-forming efficiency assays, cells were labeled for 2 h at the indicated doses. The labeled cells were then trypsinized, washed to remove label, and replated in duplicate culture dishes at 1000 and 2000 cells/dish. Cells were fed with complete M199 medium every other day for 7 days, after which they were fixed and stained with 0.25% crystal violet in 2% formaldehyde/80% methanol. The colonies (which were defined as a minimum of 100 cells in a cluster) were counted manually for both labeled and unlabeled (control) samples and percent colony formation was corrected according to the plating efficiency (PE) of the control cells. Percent colony formation ϭ 100 ϫ number of colonies established/number of cells seeded ϫ PE, where PE ϭ number of colonies established by unlabeled cells/total number of cells seeded. PE for the experiment shown in Fig. 5 was ϳ36%.
Morphological analyses
Cell morphology after radiolabeling was examined by both bright-field and fluorescence microscopy using an Olympus IX70-inverted system microscope equipped with an IX-FLA inverted reflected light fluorescence observation attachment. Pictures were recorded with an Olympus PM-20 photomicrographic system using both 20ϫ and 40ϫ objectives on the microscope. Some samples were fixed and stained with PI as described above to better identify morphological changes in cell nuclei.
Apoptosis assay
Cells were washed with PBS and stained with annexin VOregon Green (Trevigen, Inc.) [250 g/ml] for 15 min in the dark. The live cells were then examined with an inverted fluorescence microscope, and both phase contrast and fluorescence images were recorded photographically. To quantitate apoptosis, the number of Oregon Green-stained cells were counted and divided by the total number of cells in the area examined. To facilitate cell count and to preserve the cell-associated fluroescence for a longer period of time, the radiolabeled cells were fixed with cold methanol after staining live cells with annexin V-Oregon Green and also stained with PI to highlight the nuclei. The number of Oregon Green-stained cells in both radiolabeled and control samples were counted within a 10 ϫ 10 grid on the fluorescence microscope and divided by the number of nuclei (or total cell number) in the same area.
Statistical analyses
All data are expressed as means Ϯ se. The Student's t test was used to determine statistical significance of the difference between labeled samples vs. matched controls.
RESULTS AND DISCUSSION
Metabolic labeling with [
S]methionine inhibits cell progression into mitosis
Mitotic cells are often harvested from cell cultures treated with nocodazole, a microtubule-disrupting drug commonly used to induce mitotic arrest (14) . Figure 1 shows that metabolic labeling of rabbit smooth muscle cells with [ 35 S]methionine at 100 Ci/ml prevents the normal accumulation of mitotic cells in the presence of nocodazole. Neither the commercial source of the label nor the composition of the carrier buffer was a factor in this inhibition, as shown in Fig. 1 . In separate studies, removal of the label after an overnight or a 2 h pulse labeling period also failed to reverse the inhibition (data not shown). The effect of a 30 min prelabeling amino acid depletion protocol was considered as a possible cause of mitotic inhibition despite ample mitotic cell accumulation in the similarly starved unlabeled control. This possibility was ruled out by the observations that decreasing the preincubation time with depleted medium to 5 min and labeling of cells in complete medium (without any starvation period) had no influence on the inhibitory effects of the radiolabel on mitotic induction. Furthermore, the effect of [
35 S]methionine was not cell type specific, as several different cell lines were similarly inhibited in terms of entry into mitosis (Fig. 2) . Thus, we postulated that exposure to standard amounts of [
35 S]methionine induced a form of cell cycle arrest.
S-methionine induces cell cycle arrest
This postulate was confirmed by cell cycle analyses using PI staining for DNA content and adapted for analysis of anchored cells using scanning laser cytometry (13) . As shown in Fig. 3A , unlabeled cells synchronized at the G1/S transition by a thymidinemimosine double block procedure (12) are characterized by a single peak in the fluorescence profile of PI-stained cells, representing cells with 2n DNA content immediately after washout of mimosine. Figure 3B shows the appearance of the G2 peak 8 h after release from the mimosine block, with the G2 peak having a mean fluorescence value approximately twice that of the G1 peak, corresponding to cells with 4n DNA content. Figure 3C shows that 24 h after the mimosine washout, a large fraction of unlabeled control cells had returned to G1 and were proceeding once again into S phase. At the same time point, a sample that had been labeled for 2 h with [ 35 S]methionine immediately after washout of mimosine and chased with cold complete medium for 22 h was still predominantly in the initial G2 phase (Fig. 3D) , having never rounded up. Since all cells in this experiment had been previously synchronized to the G1/S interface, these studies suggest that [ mally associated with G1 arrest. In light of our observations of a [
35 S]methionine-induced G2 arrest, several possibilities can be considered: 1) elevated p53 levels can also induce G2 arrest, as reported elsewhere (15) (16) (17) (18) ; 2) a p53-independent mechanism is involved in radioisotope-induced cell cycle arrest, as has been suggested for other forms of irradiation (3, 5); 3) the stage and/or mechanism of cell cycle arrest may be dependent on the cell cycle compartment in which the label is introduced or on the cell type involved. The resolution of these possibilities awaits further experimentation.
S-metabolic labeling inhibits cell proliferation
To investigate the effect of metabolic labeling on cell proliferation, rabbit smooth muscle cells labeled for 2 h with [ 35 S]methionine were washed thoroughly to remove label and cultured for additional periods of time. Figure 4 shows that whereas the unlabeled control cells increased in number over the course of 3 days, the labeled cells showed no increase and, in some experiments, decreased in number (data not shown). Colony-forming efficiency assays were conducted at different concentrations of 35 S-Trans label to assess the effects of varying doses of radiolabel on long-term survival and proliferation of cells. The results (Fig. 5A ) not only show that cells labeled for 2 h at 100 Ci/ml failed to form colonies over a period of 7 days, but also that a 1000-fold reduction in the radioisotope concentration to 0.1 Ci/ml yields a 40% reduction in the number of colonies formed relative to unlabeled control cells. When expressed as a function of pCi uptake/ cell (Fig. 5B) , it is clear that the inhibition of colony formation correlates directly with the amount of radioactivity incorporated. Furthermore, relatively few atoms of 35 S [0.07 pCi/cell corresponds to ϳ36,000 molecules of radiolabel] can cause substantial inhibition of cell proliferation (ϳ 40%), suggesting that critical targets may be damaged by this low-energy beta emitter. It will be interesting to determine the exact nature of the target(s) as well as its relation to cell cycle progression and apoptosis. It is noteworthy that there were still some live cells in the dishes labeled at 100 Ci/ml, some of which appeared to have undergone a few rounds of replication. However, these cells were altered in morphology (see below), and the number of such cells in a cluster did not meet the criterion set for a 'colony'. It remains to be seen whether the surviving cells in these small clusters are transiently growtharrested, terminally differentiated, or altered with respect to the length of the cell cycle. The colonyforming efficiency assays thus indicate that even very low levels of radiolabeling (0.1-1 Ci/ml) can induce inhibition of cell proliferation and/or cell death.
Radiolabeling dramatically alters cell morphology
Along with the inhibition of cell proliferation, we observed dramatic changes in cell morphology for the radiolabeled smooth muscle cells from predominantly spindle-shaped cells (Fig. 6A) to enlarged, multinucleated, irregularly shaped cells (Figs. 6B, C) . Yeargin and Haas (3) also reported that radiolabeling of human foreskin fibroblasts induced the appearance of large, senescent-like cells that remained quiescent for 17 days. PI-staining confirmed the presence of multinucleated cells as well as cells with fragmented nuclei (Figs. 6E, F) . These morphological changes prompted us to examine the effects of 
Radiolabeling induces delayed apoptosis of cells
Labeled and unlabeled cells were examined for signs of apoptosis using a fluorescent conjugate of an- nexin V, a protein that strongly and specifically binds to phophatidylserine (PS), which flips from the inner to the outer monolayer of the plasma membrane as the cell undergoes apoptosis. The resulting exposure of PS on the cell surface as detected by annexin V binding is often taken as a marker for early stages of apoptosis and occurs well before DNA fragmentation or trypan blue staining is detectable (19) . Figure 7 shows that radiolabeled cells showed an enhancement of apoptosis in comparison to unlabeled control cells. The amount of apoptosis in radiolabeled cell cultures was comparable to or exceeded the amount of apoptosis induced by exposure of these cells to chromium, an environmental toxin previously shown to induce apoptosis (20) . The degree of apoptosis increased as a function of time after a 2 h exposure to radiolabel, suggesting that metabolic radiolabeling and incorporated [ 35 S]methionine can induce delayed apoptosis. By contrast, trypan blue staining immediately after the 2 h labeling period did not show any significant decrease in cell viability (data not shown).
The results described collectively suggest that low level beta emitters, particularly [
35 S]methionine at the concentration typically used in metabolic labeling experiments, can cause cell cycle arrest, longterm inhibition of proliferation, and apoptosis of cells. These results may not be so surprising if one considers the amount of radioactive decay energy the cell is exposed to during labeling as well as after metabolic incorporation of the radiolabel. An estimate of the initial dose rate or energy emitted by 100 Ci (21) . After a cellular uptake of ϳ40% of the label (present initially at 100 Ci/ml), the amount of energy released per cell/h is 230 MeV per cell/h or 2.3 ϫ 10 Ϫ4 erg per cell/h (Appendix 2). Our colony-forming assays also show that even very low levels of radioisotope uptake (e.g.,. 0.07 pCi/cell) can cause significant inhibition of cell proliferation. Thus, these results and calculations suggest a substantial potential for DNA and/or cellular damage by ionizing beta radiation from incorporated 35 S atoms, as evidenced by earlier radiotoxicity assays (5) . In view of this and earlier studies (2, 3, 5) , we suggest that caution should be exercised in using metabolic radiolabeling techniques (especially for experiments involving cycling cells) as well as in evaluating and interpreting the literature involving the application of these methods. Furthermore, efforts should be directed toward finding alternative methods for following the biosynthesis, modification, and degradation of proteins in vivo. One possible alternative might involve the use of stable isotopes to follow protein expression and modification (22) . Aside from the obvious impact on experimental design, these results would also suggest the reevaluation of acceptable exposure levels to low-energy beta-emitting radioisotopes in the workplace, clinic, and environment.
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APPENDIX 1
Calculation of initial dose rate for cells exposed to 100 Ci 35 S-methionine:
Cells: monolayer of cells in 35 mm culture dish in 1 ml medium Estimated mass of region irradiated during first hour: ϳ1 g [1 ml medium ϩ cells] Concentration of label: 100 Ci of 35 S-methionine/ml ϳ 100 Ci/g Average beta energy of 35 S: 0.049 MeV/disintegration 1 millirad ϭ 62,500 MeV/g 
